Salesforce (CRM) Stock Forecast & Price Target

$165.94 -0.17 (-0.10%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$166.28 +0.34 (+0.20%)

As of 07/2/2026 07:59 PM Eastern

Compare

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 45 Analyst Ratings

Sell
4

Hold
12

Buy
29

Based on 45 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 45 analysts, 4 have given a sell rating, 12 have given a hold rating, 28 have given a buy rating, and 1 has given a strong buy rating for CRM.

Consensus Price Target

$254.42
53.32% Upside

According to the 45 analysts' twelve-month price targets for Salesforce, the average price target is $254.42. The highest price target for CRM is $400.00, while the lowest price target for CRM is $160.00. The average price target represents a forecasted upside of 53.32% from the current price of $165.94.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRM Analyst Ratings Over Time

Type	Current Forecast 7/3/25 to 7/3/26	1 Month Ago 6/3/25 to 6/3/26	3 Months Ago 4/4/25 to 4/4/26	1 Year Ago 7/3/24 to 7/3/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	3 Strong Buy rating(s)
Buy	28 Buy rating(s)	27 Buy rating(s)	26 Buy rating(s)	28 Buy rating(s)
Hold	12 Hold rating(s)	9 Hold rating(s)	11 Hold rating(s)	8 Hold rating(s)
Sell	4 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$254.42	$259.26	$280.21	$349.08
Forecasted Upside	53.32% Upside	35.77% Upside	49.84% Upside	28.54% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	Broader Market
Consensus Rating Score	2.58	2.28	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	53.32% Upside	173.55% Upside	13.31% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/1/2026	Raymond James Financial 3 of 5 stars		Initiated Coverage	Strong-Buy ➝ Outperform
7/1/2026	Royal Bank Of Canada 3 of 5 stars		Downgrade	Sector Perform
7/1/2026	Truist Financial 3 of 5 stars		Downgrade	Strong-Buy ➝ Market Perform
7/1/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform
7/1/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Buy
7/1/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Market Outperform ➝ Overweight
7/1/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Market Outperform ➝ Buy
7/1/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform
7/1/2026	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Neutral
7/1/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$228.00	+45.23%
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
6/29/2026	Phillip Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$253.00 ➝ $166.00	+4.91%
6/18/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Overweight
6/18/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Sector Outperform ➝ Sector Perform
6/18/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Negative
6/18/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy ➝ Neutral
6/18/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$200.00	+29.13%
6/17/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C-) ➝ Sell (D+)
6/16/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
6/16/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$225.00	+38.43%
6/12/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
6/2/2026	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$295.00 ➝ $280.00	+53.24%
5/29/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$350.00 ➝ $356.00	+86.39%
5/28/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
5/28/2026	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$325.00	+82.72%
5/28/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$300.00 ➝ $290.00	+63.05%
5/28/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Underperform	$194.00 ➝ $173.00	-3.50%
5/28/2026	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Koenig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$200.00 ➝ $190.00	+5.84%
5/28/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$315.00	+75.38%
5/28/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$210.00 ➝ $200.00	+11.36%
5/28/2026	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$205.00 ➝ $240.00	+33.36%
5/28/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$250.00	+38.92%
5/28/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$200.00 ➝ $175.00	-2.76%
5/28/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$225.00 ➝ $215.00	+21.11%
5/26/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$255.00	+41.41%
5/18/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tal Liani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy ➝ Underperform	$160.00	-7.93%
3/10/2026	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Perform	$267.00 ➝ $229.00	+15.24%
2/26/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $250.00	+30.08%
2/26/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$365.00 ➝ $320.00	+60.50%
2/26/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$280.00 ➝ $265.00	+33.78%
2/26/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$300.00 ➝ $250.00	+27.84%
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
2/23/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$398.00 ➝ $287.00	+55.05%
12/11/2025	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
12/4/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$340.00 ➝ $360.00	+49.91%
12/4/2025	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kirk Materne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$360.00 ➝ $340.00	+42.58%
12/4/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$325.00 ➝ $315.00	+32.09%
6/5/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/30/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$311.00 ➝ $309.00	+16.88%
5/28/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$320.00	+15.55%
2/27/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$330.00 ➝ $300.00	+0.80%
2/19/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omar Sheikh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy
10/17/2024	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$343.00	+16.88%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shebly Seyrafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stefan Slowinski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:30 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 1, 2026. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

Salesforce, Inc. has demonstrated strong financial performance with a net margin of nearly 19%, indicating effective cost management and profitability.
The company reported a revenue increase of over 13% year-over-year, showcasing its growth potential and ability to expand its market share.
Salesforce, Inc. has initiated a substantial stock repurchase program, allowing for the buyback of up to $25 billion in shares, which often signals that the company believes its stock is undervalued and can enhance shareholder value.
The current stock price is around $720, reflecting investor confidence and market interest in Salesforce, Inc.'s growth trajectory.
With a dividend yield of approximately 1.1% and a payout ratio of 20.37%, investors can expect a steady income stream while benefiting from potential capital appreciation.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

Despite strong revenue growth, the company faces increasing competition in the cloud-based software market, which could impact its market share and pricing power.
The anticipated earnings per share for the current fiscal year is around 10.29, which may not meet the high expectations set by investors, potentially leading to stock price volatility.
Salesforce, Inc.'s reliance on a subscription-based model means that any downturn in customer retention or acquisition could significantly affect its revenue stability.
The company has set ambitious guidance for future earnings, which may be challenging to achieve in a competitive landscape, raising concerns about its ability to deliver consistent growth.
Market conditions and economic uncertainties could adversely affect Salesforce, Inc.'s performance, making it a riskier investment in the current environment.

CRM Forecast - Frequently Asked Questions

According to the research reports of 45 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $254.42, with a high forecast of $400.00 and a low forecast of $160.00.

45 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There are currently 4 sell ratings, 12 hold ratings, 28 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 53.32% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 9 downgrades and 6 upgrades by analysts.

Salesforce has been rated by research analysts at B. Riley Financial, Bank of America, Barclays, BMO Capital Markets, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Citizens Jmp, DA Davidson, Daiwa Securities Group, Guggenheim, HC Wainwright, HSBC, Jefferies Financial Group, KeyCorp, Macquarie Infrastructure, Monness Crespi & Hardt, Needham & Company LLC, Phillip Securities, Piper Sandler, Raymond James Financial, Roth Mkm, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Susquehanna, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating for Salesforce is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

This page (NYSE:CRM) was last updated on 7/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CRM Analyst Ratings Over Time

CRM Analyst Recommendations By Month

CRM Price Targets by Month

Salesforce Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

Salesforce
Bull Case

Salesforce
Bear Case

CRM Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Salesforce (CRM) Stock Forecast & Price Target

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CRM Analyst Ratings Over Time

CRM Analyst Recommendations By Month

CRM Price Targets by Month

Salesforce Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

Salesforce Bull Case

Salesforce Bear Case

CRM Forecast - Frequently Asked Questions

What is Salesforce's forecast for 2026?

Should I buy or sell Salesforce stock right now?

Does Salesforce's stock price have much upside?

Has Salesforce been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Salesforce?

Do Wall Street analysts like Salesforce more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Salesforce
Bull Case

Salesforce
Bear Case